Postmastectomy radiation and survival in older women with breast cancer

Journal of Clinical Oncology

Volumn 24, Issue 30, 2006, Pages 4901-4907

  Smith, Benjamin D ^a   Haffty, Bruce G ^a   Hurria, Arti ^a   Galusha, Deron H ^a   Gross, Cary P ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; COVARIANCE; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; TREATMENT OUTCOME; ADJUVANT THERAPY; AGE; BREAST TUMOR; CANCER REGISTRY; MULTIMODALITY CANCER THERAPY; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICS; SURVIVAL;

AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MASTECTOMY; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEER PROGRAM; SURVIVAL ANALYSIS;

EID: 33750615608     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.06.5938     Document Type: Article

References (54)

1. Surveillance, Epidemiology, and End Results (SEER) Program: SEER*Stat Database: Incidence - SEER 13 Regs Public-Use. National Cancer Institute, April 2004. http://seer.cancer.gov/publicdata/citation.html
2. Edwards BK, Howe HL, Ries LA, et al: Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer 94:2766-2792, 2002
3. Overgaard M, Hansen PS, Overgaard J, et al: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy: Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337:949-955, 1997
4. Overgaard M, Jensen MB, Overgaard J, et al: Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353:1641-1648, 1999
5. Ragaz J, Jackson SM, Le N, et al: Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337:956-962, 1997
6. Ragaz J, Olivotto IA, Spinelli JJ, et al: Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 97:116-126, 2005
7. Early Breast Cancer Trialists' Collaborative Group: Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 365:1687-1717, 2005
8. Trimble EL, Carter CL, Cain D, et al: Representation of older patients in cancer treatment trials. Cancer 74:2208-2214, 1994
9. Hutchins LF, Unger JM, Crowley JJ, et al: Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 341: 2061-2067, 1999
10. Clarke M, Collins R, Darby S, et al: Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 366:2087-2106, 2005
11. Carlson RW, Anderson BO, Burstein HJ, et al: Breast cancer. J Natl Compr Cane Netw 3:238-289, 2005
12. Recht A, Edge SB, Solin LJ, et al: Postmastectomy radiotherapy: Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19:1539-1569, 2001
13. Diab SG, Elledge RM, Clark GM: Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 92:550-556, 2000
14. Wyld L, Reed MW: The need for targeted research into breast cancer in the elderly. Br J Surg 90:388-399, 2003
15. Vicini FA, Recht A: Age at diagnosis and outcome for women with ductal carcinoma-in-situ of the breast: A critical review of the literature. J Clin Oncol 20:2736-2744, 2002
16. Jobsen JJ, van der Palen J, Meerwaldt JH: The impact of age on local control in women with pT1 breast cancer treated with conservative surgery and radiation therapy. Eur J Cancer 37:1820-1827, 2001
17. Harrold EV, Turner BC, Matloff ET, et al: Local recurrence in the conservatively treated breast cancer patient: A correlation with age and family history. Cancer J Sci Am 4:302-307, 1998
18. Hughes KS, Schnaper LA, Berry D, et al: Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351:971-977, 2004
19. Warren JL, Klabunde CN, Schrag D, et al: Overview of the SEER-Medicare data: Content, research applications, and generalizability to the United States elderly population. Med Care 40:IV-3-18, 2002
20. Kirschner CG, Edwards NK, May DM, et al: Physicians' Current Procedural Terminology (ed 4). Chicago, IL, American Medical Association, 1991
21. Bach PB, Guadagnoli E, Schrag D, et al: Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care 40:IV-19-25, 2002
22. Du X, Freeman JL, Warren JL, et al: Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer. Med Care 38:719-727, 2000
23. Practice Management Information Corporation: International Classification of Diseases, (9th rev; ed 3) Clinical Modification, Volumes 1, 2 & 3. Los Angeles, CA, Practice Management Information Corporation, 1991
24. Buck CJ: 2002 ICD-9-CM, Volumes 1, 2, and 3 and HCPCS Level II. Philadelphia, PA, W.B. Saunders Company, 2002
25. Anderson CA, Beebe M, Dalton JA, et al: Current Procedural Terminology CPT 2002. Chicago, IL, American Medical Association, 2002
26. Virnig BA, Warren JL, Cooper GS, et al: Studying radiation therapy using SEER-Medicare-linked data. Med Care 40:IV-49-54, 2002
27. Du X, Freeman JL, Goodwin JS: Information on radiation treatment in patients with breast cancer: The advantages of the linked Medicare and SEER data: Surveillance, Epidemiology and End Results. J Clin Epidemiol 52:463-470, 1999
28. Warren JL, Harlan LC, Fahey A, et al: Utility of the SEER-Medicare data to identify chemotherapy use. Med Care 40:IV-55-61, 2002
29. Du XL, Chan W, Giordano S, et al: Variation in modes of chemotherapy administration for breast carcinoma and association with hospitalization for chemotherapy-related toxicity. Cancer 104:913-924, 2005
30. Osborne C, Ostir GV, Du X, et al: The influence of marital status on the stage at diagnosis, treatment, and survival of older women with breast cancer. Breast Cancer Res Treat 93:41-47, 2005
31. Keating NL, Landrum MB, Guadagnoli E, et al: Factors related to underuse of surveillance mammography among breast cancer survivors. J Clin Oncol 24:85-94, 2006
32. Keating NL, Landrum MB, Ayanian JZ, et al: The association of ambulatory care with breast cancer stage at diagnosis among Medicare beneficiaries. J Gen Intern Med 20:38-44, 2005
33. Charlson ME, Pompei P, Ales KL, et al: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40:373-383, 1987
34. Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613-619, 1992
35. Romano PS, Roos LL, Jollis JG: Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives. J Clin Epidemiol 46:1075-1079, 1993; discussion 1081-1090, 1993
36. Klabunde CN, Potosky AL, Legler JM, et al: Development of a comorbidity index using physician claims data. J Clin Epidemiol 53:1258-1267, 2000
37. Klabunde CN, Warren JL, Legler JM: Assessing comorbidity using claims data: An overview. Med Care 40:IV-26-35, 2002
38. Earle CC: Influenza vaccination in elderly patients with advanced colorectal cancer. J Clin Oncol 21:1161-1166, 2003
39. Pham HH, Schrag D, Hargraves JL, et al: Delivery of preventive services to older adults by primary care physicians. JAMA 294:473-481, 2005
40. Percy C, Van Holten V, Muir C: International Classification of Diseases for Oncology (ed 2). Geneva, World Health Organization, 1990
41. Schrag D, Bach PB, Dahlman C, et al: Identifying and measuring hospital characteristics using the SEER-Medicare data and other claims-based sources. Med Care 40:IV-96-103, 2002
42. Harris JR, Halpin-Murphy P, McNeese M, et al: Consensus Statement on postmastectomy radiation therapy. Int J Radiat Oncol Biol Phys 44:989-990, 1999
43. Greene FL, Page DL, Fleming ID, et al: AJCC Cancer Staging Handbook (ed 6). New York, NY, Springer, 2002
44. Gebski V, Lagleva M, Keech A, et al: Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: A clinical perspective. J Natl Cancer Inst 98:26-38, 2006
45. Smith BD, Smith GL, Haffty BG: Postmastectomy radiation and mortality in women with T1-2 node-positive breast cancer. J Clin Oncol 23:1409-1419, 2005
46. Truong PT, Lee J, Kader HA, et al: Locoregional recurrence risks in elderly breast cancer patients treated with mastectomy without adjuvant radiotherapy. Eur J Cancer 41:1267-1277, 2005
47. Recht A, Gray R, Davidson NE, et al: Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: Experience of the Eastern Cooperative Oncology Group. J Clin Oncol 17:1689-1700, 1999
48. Taghian AG, Jeong JH, Anderson S, et al: Pattern of loco-regional and distant failure in patients with breast cancer treated with mastectomy and chemotherapy (+/- tamoxifen) without radiation: Results from five NSABP randomized trials. Int J Radiat Oncol Biol Phys 51:106a-107a, 2001 (suppl)
49. Katz A, Strom EA, Buchholz TA, et al: Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: Implications for postoperative irradiation. J Clin Oncol 18:2817-2827, 2000
50. Silliman RA, Guadagnoli E, Rakowski W, et al: Adjuvant tamoxifen prescription in women 65 years and older with primary breast cancer. J Clin Oncol 20:2680-2688, 2002
51. Fink AK, Gurwitz J, Rakowski W, et al: Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor-positive breast cancer. J Clin Oncol 22:3309-3315, 2004
52. Extermann M, Balducci L, Lyman GH: What threshold for adjuvant therapy in older breast cancer patients? J Clin Oncol 18:1709-1717, 2000
53. Li CI, Moe RE, Daling JR: Risk of mortality by histologic type of breast cancer among women aged 50 to 79 years. Arch Intern Med 163:2149-2153, 2003
54. Cristofanilli M, Gonzalez-Angulo A, Sneige N, et al: Invasive lobular carcinoma classic type: Response to primary chemotherapy and survival outcomes. J Clin Oncol 23:41-48, 2005